| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |